Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:40 am Sale | 2023-12-31 | 13G | 9 Meters Biopharma, Inc. NMTRQ | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -650,000 (Position Closed) | Filing History |
| 2023-02-09 11:51 am Purchase | 2022-12-31 | 13G | 9 Meters Biopharma, Inc. NMTRQ | ADAGE CAPITAL PARTNERS GP L.L.C. | 650,000 5.020% | 650,000 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | 9 Meters Biopharma, Inc. NMTR | BlackRock Inc. BLK | 168,540 1.300% | -539,700 (-76.20%) | Filing History |
| 2022-07-01 5:20 pm Sale | 2022-07-01 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.600% | -3,027,545 (-19.68%) | Filing History |
| 2022-02-10 10:35 am Purchase | 2021-12-31 | 13G | 9 Meters Biopharma, Inc. NMTR | ADAGE CAPITAL PARTNERS GP L.L.C. | 750,000 5.870% | 100,000 (+15.38%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | 9 Meters Biopharma, Inc. NMTR | BlackRock Inc. BLK | 708,240 5.500% | 708,240 (New Position) | Filing History |
| 2021-06-28 5:24 pm Sale | 2021-06-24 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6.000% | -17,118,837 (-52.67%) | Filing History |
| 2021-04-07 4:46 pm Unchanged | 2021-04-05 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.200% | 0 (Unchanged) | Filing History |
| 2021-03-25 5:26 pm Unchanged | 2021-03-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.600% | 0 (Unchanged) | Filing History |
| 2020-12-28 4:07 pm Purchase | 2020-12-15 | 13G | 9 Meters Biopharma, Inc. NMTR | ADAGE CAPITAL PARTNERS GP L.L.C. | 650,000 6.410% | 650,000 (New Position) | Filing History |
| 2020-12-16 5:13 pm Purchase | 2020-12-15 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 16.000% | 1,943,734 (+6.36%) | Filing History |
| 2020-12-10 10:58 am Sale | 2020-12-07 | 13G | 9 Meters Biopharma, Inc. NMTR | Capital Point Ltd. | 364,795 4.810% | -4,108 (-1.11%) | Filing History |
| 2020-09-03 5:19 pm Purchase | 2020-04-30 | 13G | 9 Meters Biopharma, Inc. NMTR | Capital Point Ltd. | 368,903 8.070% | 368,903 (New Position) | Filing History |
| 2020-07-29 1:38 pm Unchanged | 2020-07-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 21.400% | 0 (Unchanged) | Filing History |
| 2020-05-14 5:25 pm Purchase | 2020-05-04 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 27.300% | 30,559,521 (New Position) | Filing History |